{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:12:05Z","timestamp":1778760725486,"version":"3.51.4"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cmi.2026.01.025","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:04:39Z","timestamp":1770077079000},"page":"1026-1028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Visceral leishmaniasis in a woman treated with risankizumab for guttate psoriasis"],"prefix":"10.1016","volume":"32","author":[{"given":"Etienne","family":"Rivi\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Tinevez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Blaison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Viallard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estibaliz","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Camou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.01.025_bib1","first-page":"2379","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cmi.2026.01.025_bib2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1096\/fj.15-277202","article-title":"IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani","volume":"30","author":"Terrazas","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.cmi.2026.01.025_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ueg2.12740","article-title":"Leishmaniasis in patients with inflammatory bowel disease: a national multicenter study of GETECCU","volume":"13","author":"Madero-Vel\u00e1zquez","year":"2025","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.cmi.2026.01.025_bib4","first-page":"319","article-title":"Visceral leishmaniasis after anti-interleukin 17A (IL-17A) therapy in a patient affected by psoriatic arthritis","volume":"7","author":"Lupia","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.cmi.2026.01.025_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cmi.2019.10.025","article-title":"Travelling with visceral leishmaniasis","volume":"26","author":"Ahmed","year":"2020","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:48:20Z","timestamp":1778759300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1198743X26000303"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.01.025","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visceral leishmaniasis in a woman treated with risankizumab for guttate psoriasis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}